C h a p t e r 3 6
Disorders of Neuromuscular Function
915
Harrison’s Neurology in Clinical Medicine
. 2nd ed. New York:
McGraw-Hill; 2010:435–450.
47. Courtney AM, Treadaway K, Remington G, et al. Multiple
sclerosis.
Med Clin North Am.
2009;93:451–476.
48. Peterson JW, Trapp BD. Neuropathology of multiple sclerosis.
Neurol Clin.
2005;23:107–129.
49. Nylander A, Hafler DA. Multiple sclerosis.
J Clin Invest.
2012;122(4):1180–1186.
50. Frohman EM, Racke MK, Raine CS. Mulltiple sclerosis—the
plaque and its pathogenesis.
N Engl J Med.
2006;345(9):942–955.
51. Lubin DD. Clinical features and diagnosis of multiple sclerosis.
Neurol Clin.
2005;23:1–15.
52. Kita M. FDA-approved preventative therapies for MS; first-line
agents.
Neurol Clin.
2011;29:401–409.
53. NSCISC National Spinal Cord Injury Statistical Center.
Spinal
cord injury: Facts and figures at a glance
. Birmingham, AL:
University of Alabama; 2013. [Online] Available at: https://
/
Facts%202013.pdf. Accessed September 19, 2013.
54. McDonald JW. Spinal cord injury.
Lancet.
2002;359:417–425.
55. Wilson JR, Fehlings MG. Emerging approaches to the
surgical management of acute traumatic spinal cord injury.
Neurotherapeutics.
2011;8:187–194.
56. Gupta R, Bathen ME, Smith JS, et al. Advances in the
management of spinal cord injury.
J Am Acad Orthop Surg.
2010;18(4):210–222.
57. Branco F, Cardenas DD, Svircev JN. Spinal cord injury:
a comprehensive review.
Phys Med Rehabil Clin N Am.
2007;18:651–679.
58. Dietrich WD. Therapeutic hypothermia in spinal cord injury.
Crit
Care Med.
2009;37(7):S238–S243.
59. Kirshblum SC, Burns SP, Biering-Sorensen F. International
standards for neurological classification of spinal cord injury
(revised 2011).
J Spinal Cord Med.
2011;34(6):535–547.
60. Lo V, Esquenazi A, Han MK, et al. Critical care management
of patients with acute spinal cord injury.
J Neurosurg Sci.
2013;57(4):281–292.
61. Zimmer MB, Nantwi K, Goshgarian HG. Effect of spinal cord
injury on the respiratory system: basic research and current
clinical treatment options.
J Spinal Cord Med.
2007;30:319–330.
62. Garstang SV, Miller-Smith SA. Autonomic nervous system
dysfunction after spinal cord injury.
Phys Med Rehabil Clin N
Am.
2007:18, 275–296.
63. Krassioukov A, Warburton DER, Tessel R, et al. A systematic
review of the management of autonomic dysreflexia following
spinal cord injury.
Arch Phys Med Rehabil.
2009;90(4):682–695.
64. Cruz CD, Cruz F. Spinal cord injury and bladder dysfunction:
new ideas about an old problem.
Scientific World Journal.
2011;11:214–234.
65. Riccardi R, Szabo CM, Poullos AY. Sexuality and spinal cord
injury.
Nurs Clin North Am.
2007;42:677–684.
66. Tessell RW, Hsieh TJ, Aubut JAL, et al. Venous
thromboembolism following spinal cord injury.
Arch Phys Med
Rehabil.
2009;90(2):232–245.
67. Tohda C, Kuboyama T. Current and future therapeutic strategies
for functional repair of spinal cord injury.
Pharmacol Ther.
;2011;132(1):57–71.
68. Mothe A, Tator CH. Advances in stem cell therapy for spinal
cord injury.
J Clin Invest.
2012;122(11):3823–3834.
69. Wilson J, Forgione N, Fehlings MG. Emerging therapies for acute
traumatic spinal cord injury.
CMAJ.
2013;185(6):485–492.
70. Varma AK, Das A, Wallace G IV, et al. Spinal cord injury: a
review of current therapy, future treatments, and basic science
frontiers.
Neurochem Res.
2013;38:895–905.
71. Bracken MB. Steroids for acute spinal cord injury.
Cochrane
Database Syst Rev
2012;1:CD001046.
Porth Essentials Resources
Explore these additional resources to enhance learning
for this chapter:
•
NCLEX-Style Questions and Other Resources
on
,
•
Study Guide for Essentials of Pathophysiology
•
Adaptive Learning | Powered by PrepU,
prepu
